ResearchIn-Press PreviewNeuroscienceTherapeutics
Open Access | 10.1172/jci.insight.141561
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by
Zallocchi, M.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by Hati, S. in: JCI | PubMed | Google Scholar
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by Xu, Z. in: JCI | PubMed | Google Scholar
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by Hausman, W. in: JCI | PubMed | Google Scholar
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by Liu, H. in: JCI | PubMed | Google Scholar
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by
He, D.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Biomedical Sciences, Creighton University, Omaha, United States of America
Find articles by Zuo, J. in: JCI | PubMed | Google Scholar
Published January 21, 2021 - More info
Hair cell loss is the leading cause of hearing and balance disorders in humans. It can be caused by many factors, including noise, aging, and therapeutic agents. Previous studies have shown the therapeutic potential of quinoxaline against drug-induced ototoxicity. Here, we screened a library of 68 quinoxaline derivatives for protection against aminoglycoside-induced damage of hair cells from the zebrafish lateral line. We identified Qx28 as the best quinoxaline derivative that provides robust protection against both aminoglycosides and cisplatin in zebrafish and mouse cochlear explants. FM1-43 and aminoglycoside uptake, as well as antibiotic efficacy studies, reveal that Qx28 is neither blocking the mechanotransduction channels nor interfering with aminoglycoside antibacterial activity, suggesting that it may be protecting the hair cells by directly counteracting the ototoxin’s mechanism of action. Only when animals were incubated with higher doses of Qx28 we observed a partial blockage of the mechanotransduction channels. Finally, we assessed the regulation of NF-κB pathway in vitro in mouse embryonic fibroblasts and in vivo in zebrafish larvae. Those studies showed that Qx28 protects hair cells by blocking NF-κB canonical pathway activation. Thus, Qx28 is a promising and versatile otoprotectant that can act across different species and toxins.